Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 505 results

Search term: MF = 'C_{29}H_{35}ClN_{2}O_{4}'
12345
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
2944868
InChI=1/C29H35ClN2O4/c1-16-24(17(2)32(31-16)15-18-9-7-8-10-19(18)30)27(25-20(33)11-28(3,4)12-21(25)34)26-22(35)13-29(5,6)14-23(26)36/h7-10,25-27H,11-15H2,1-6H3
C29H35ClN2O4511.052214900
9773461
InChI=1/C29H32N2O3.ClH.H2O/c1-21-27-19-25(33)11-14-28(27)31(29(21)23-7-9-24(32)10-8-23)20-22-5-12-26(13-6-22)34-18-17-30-15-3-2-4-16-30;;/h5-14,19,32-33H,2-4,15-18,20H2,1H3;1H;1H2
C29H35ClN2O4511.0522111200
4220000

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H35ClN2O4/c1-4-6-7-8-17-31-28(34)23-11-9-21(10-12-23)19-32-20(3)27(29(35)36-5-2)25(18-26(32)33)22-13-15-24(30)16-14-22/h9-16,25H,4-8,17-19H2,1-3H3,(H,31,34)
C29H35ClN2O4511.05229700
25062744

1 of 1 defined stereocentres - 1/1 defined
InChI=1/C29H34N2O4.ClH/c1-4-34-28(33)14-11-21-10-13-27(25(15-21)18-30)35-20-26(32)19-31-29(2,3)17-22-9-12-23-7-5-6-8-24(23)16-22;/h5-10,12-13,15-16,26,31-32H,4,11,14,17,19-20H2,1-3H3;1H/t26-;/m1./s1
C29H35ClN2O4511.05228300
58174266

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C29H35ClN2O4/c1-35-15-14-31(18-21-10-7-13-32-12-6-5-11-26(21)32)19-24-28(34)25(30)16-23-22(17-27(33)36-29(23)24)20-8-3-2-4-9-20/h2-4,8-9,16-17,21,26,34H,5-7,10-15,18-19H2,1H3/t21-,26+/m0/s1
C29H35ClN2O4511.05227500
3892943

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H35ClN2O4/c1-4-7-8-9-18-35-22-13-10-20(11-14-22)26-25-27(33)23-19-21(30)12-15-24(23)36-28(25)29(34)32(26)17-16-31(5-2)6-3/h10-15,19,26H,4-9,16-18H2,1-3H3
C29H35ClN2O4511.05226600
22216934

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H35ClN2O4/c1-31-10-4-5-21(16-31)19-35-28-15-23(22-6-3-7-25(30)14-22)13-24-17-32(11-12-34-29(24)28)18-26-8-9-27(36-26)20-33-2/h3,6-9,13-15,21H,4-5,10-12,16-20H2,1-2H3
C29H35ClN2O4511.05225400
68388748

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H35ClN2O4/c1-22-5-11-26(30)27(17-22)36-21-29(34)13-3-14-31(20-29)19-24-7-9-25(10-8-24)35-16-4-15-32-18-23(2)6-12-28(32)33/h5-12,17-18,34H,3-4,13-16,19-21H2,1-2H3
C29H35ClN2O4511.05224300
68399539
InChI=1/C29H35ClN2O4/c1-23-7-12-28(33)32(20-23)15-4-18-35-26-10-8-24(9-11-26)21-31-16-13-29(34-2,14-17-31)22-36-27-6-3-5-25(30)19-27/h3,5-12,19-20H,4,13-18,21-22H2,1-2H3
C29H35ClN2O4511.05224300
114990542
InChI=1/C29H35ClN2O4/c30-17-7-1-2-8-19-35-21-22-36-20-18-31-28(33)15-16-29(34)32-23-26-11-4-3-9-24(26)13-14-25-10-5-6-12-27(25)32/h3-6,9-12H,1-2,7-8,15-23H2,(H,31,33)
C29H35ClN2O4511.05224400
32699728

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C29H33ClN2O3.H2O/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32(35)20-17-28(34,18-21-32)23-13-15-26(30)16-14-23;/h3-16,34H,17-22H2,1-2H3;1H2/t28-,32-;
C29H35ClN2O4511.05223500
34992572

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C29H33ClN2O3.H2O/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32(35)20-17-28(34,18-21-32)23-13-15-26(30)16-14-23;/h3-16,34H,17-22H2,1-2H3;1H2/t28-,32+;
C29H35ClN2O4511.05223400
68410769
InChI=1/C29H35ClN2O4/c1-22-4-10-26(30)27(18-22)36-21-29(34)12-15-31(16-13-29)20-24-6-8-25(9-7-24)35-17-3-14-32-19-23(2)5-11-28(32)33/h4-11,18-19,34H,3,12-17,20-21H2,1-2H3
C29H35ClN2O4511.05223200
68425508

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H35ClN2O4/c1-21-15-25(9-10-26(21)30)35-20-29(18-27(33)31-11-5-2-6-12-31)19-32(13-14-36-29)28(34)24-16-22-7-3-4-8-23(22)17-24/h3-4,7-10,15,24H,2,5-6,11-14,16-20H2,1H3
C29H35ClN2O4511.05223200
80805765
InChI=1/C29H35ClN2O4/c30-24-17-21(18-26-28(24)36-16-15-35-26)19-27(33)31-13-7-3-1-2-4-8-14-32(29(34)22-11-12-22)25-10-6-5-9-23(25)20-31/h5-6,9-10,17-18,22H,1-4,7-8,11-16,19-20H2
C29H35ClN2O4511.05223300
80820157

1 of 1 defined stereocentres - 1/1 defined
InChI=1/C29H35ClN2O4/c30-23-11-9-22(10-12-23)27(33)31-17-14-29(15-18-31)13-3-4-19-35-20-24-6-5-16-32(24)28(34)25-7-1-2-8-26(25)36-21-29/h1-2,7-12,24H,3-6,13-21H2/t24-/m0/s1
C29H35ClN2O4511.05223300
80820165

1 of 1 defined stereocentres - 1/1 defined
InChI=1/C29H35ClN2O4/c30-25-11-3-1-9-23(25)27(33)31-17-14-29(15-18-31)13-5-6-19-35-20-22-8-7-16-32(22)28(34)24-10-2-4-12-26(24)36-21-29/h1-4,9-12,22H,5-8,13-21H2/t22-/m0/s1
C29H35ClN2O4511.05223300
8567075

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H34N2O4.ClH/c1-34-26-14-12-24(13-15-26)31-19-17-30(18-20-31)21-25(32)22-35-29-10-6-5-9-27(29)28(33)16-11-23-7-3-2-4-8-23;/h2-10,12-15,25,32H,11,16-22H2,1H3;1H
C29H35ClN2O4511.05223300
24782690
InChI=1/C29H35ClN2O4/c1-7-31(8-2)23-15-17-24(18-16-23)32-19(5)25(28(33)35-9-3)27(21-11-13-22(30)14-12-21)26(20(32)6)29(34)36-10-4/h11-18,27H,7-10H2,1-6H3
C29H35ClN2O4511.05222200
28522722

Charge
InChI=1/C29H35N2O4.ClH/c1-31-24-11-12-25(32-2)29(33-14-6-13-30-21-7-4-3-5-8-21)23(24)15-20-10-9-19-16-26-27(35-18-34-26)17-22(19)28(20)31;/h11-12,15-17,21,30H,3-10,13-14,18H2,1-2H3;1H/q+1;/p-1
C29H35ClN2O4511.05222200
12345

Advertisement